Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL RECEIVABLES
Total Receivables RARE - Ultragenyx Pharmaceutical Inc.
73.4 M
LAST VALUE
60.66%
2 YEAR CAGR
41.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR